Under construction

logo.jpg

Dedicated to precision oncology, Amoy Diagnostics Co., Ltd. (AmoyDx) provides state-of-the-art molecular diagnostic products and services to various customers including but not limited to healthcare providers, academic institutions and pharmaceutical companies. AmoyDx has a rich portfolio of test kits that mainly focuses on oncology target therapy companion diagnostics. 

 

AmoyDx has been diagnostic partner of several major pharmaceutical companies such as AstraZeneca and Pfizer, for personalized healthcare in various regions. Of note, AmoyDx ROS1 fusion detection kit has been used as companion diagnostic test for pivotal clinical trial of Pfizer’s Crizotinib in China, Japan and Korea.

Powered by Medikonia Limited 2019